OPEN END TURBO OPTIONSSCHEIN SHORT - FRESENIUS MEDICAL CARE Share Price

Certificat

DE000GQ4J9T5

Market Closed - BOERSE MUENCHEN 19:25:05 21/06/2024 BST
0.706 EUR +15.55% Intraday chart for OPEN END TURBO OPTIONSSCHEIN SHORT - FRESENIUS MEDICAL CARE
Current month+101.71%
1 month+119.94%
Date Price Change
21/06/24 0.706 +15.55%
20/06/24 0.611 -9.75%
19/06/24 0.677 +15.33%
18/06/24 0.587 +8.30%
17/06/24 0.542 +31.55%

Real-time BOERSE MUENCHEN

Last update June 21, 2024 at 07:25 pm

More quotes

Static data

Product typeCertificat Turbo
Buy / SellPUT
Underlying FRESENIUS MEDICAL CARE AG
Issuer Goldman Sachs
WKN GQ4J9T
ISINDE000GQ4J9T5
Date issued 06/09/2023
Strike 42.55
Maturity Unlimited
Parity 10 : 1
Emission price 0.14
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 1.287
Lowest since issue 0.089

Company Profile

Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.
Sector
-
More about the company

Ratings for Fresenius Medical Care AG

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius Medical Care AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
35.36 EUR
Average target price
39.97 EUR
Spread / Average Target
+13.05%
Consensus